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Memory CD8+ T cells are critical for long-term immu-
nity, but the genetic pathways governing their forma-
tion remain poorly defined. This study shows that the
IL-10-IL-21-STAT3 pathway is critical for memory
CD8+ T cell development after acute LCMV infection.
In the absence of either interleukin-10 (IL-10) and
IL-21 or STAT3, virus-specific CD8+ T cells retain
terminal effector (TE) differentiation states and fail
to mature into protective memory T cells that contain
self-renewing central memory T cells. Expression of
Eomes, BCL-6, Blimp-1, and SOCS3 was consider-
ably reduced in STAT3-deficient memory CD8+
T cells, and BCL-6- or SOCS3-deficient CD8+
T cells also had perturbedmemory cell development.
Reduced SOCS3 expression rendered STAT3-defi-
cient CD8+ T cells hyperresponsive to IL-12, suggest-
ing that the STAT3-SOCS3 pathway helps to insulate
memory precursor cells from inflammatory cytokines
that drive TE differentiation. Thus, memory CD8+
T cell precursor maturation is an active process
dependent on IL-10-IL-21-STAT3 signaling.
INTRODUCTION
Memory CD8+ T cells are an important component of long-term
immunity against infectious disease. Their ability to protect
depends on their longevity and other cardinal features such as
their robust capacity to proliferate and develop effector functions
when antigen is re-encountered (Cui and Kaech, 2010; Kaech
and Wherry, 2007; Sallusto et al., 2010). How these memory
T cell qualities are acquired and maintained by the pathogen-
specific CD8+ T cells that form thememory T cell pool after infec-
tion is not well understood.
Together with antigen, cytokines, and the Janus Kinase-Signal
Transducer and Activator of Transcription (JAK-STAT) path-
ways, they are essential mediators of T cell differentiation, func-
tion, and survival during immune responses (O’Shea et al., 2011;
Shuai and Liu, 2003). Prior work has shown that intense or pro-
longed exposure to antigen and inflammatory cytokines, such
as IL-2, IL-12, IFN-g, and type I IFNs, which signal through
STAT-1, -2, -4 and -5, maximize effector CD8+ T cell proliferation
and differentiation to aid pathogen clearance (Agarwal et al.,792 Immunity 35, 792–805, November 23, 2011 ª2011 Elsevier Inc.2009; Badovinac et al., 2005; Badovinac et al., 2004; Cui and
Kaech, 2010; Joshi et al., 2007; Kalia et al., 2010; Kolumam
et al., 2005; Nguyen et al., 2002). However, these signals also
modulate memory cell fate because they drive formation of
terminal effector (TE) CD8+ T cells, which, despite their important
role in pathogen clearance, are less fit to persist and populate the
memory cell pool and acquire cardinal memory cell properties
(Badovinac et al., 2005; Badovinac et al., 2004; Cui et al.,
2009; Joshi et al., 2007; Kalia et al., 2010; Pipkin et al., 2010;
Sarkar et al., 2008). These inflammatory cytokines enhance
CD8+ TE cell formation via the transcription factors T-bet
(Tbx21) and Blimp-1 (Prdm1), and in some cases, TE cells can
be distinguished from memory precursor cells (MPCs) by
increased KLRG1 and decreased IL-7Ra expression (Badovinac
et al., 2005; Badovinac et al., 2004; Cui et al., 2009; Joshi et al.,
2007; Kaech and Wherry, 2007; Kalia et al., 2010; Kallies et al.,
2009; Pipkin et al., 2010; Rutishauser et al., 2009; Sarkar
et al., 2008).
It is unclear how the MPC subset forms during infection and
circumvents the signals that promote TE differentiation. One
possibility is that, like TE fates, MPC fates are induced and
sustained over time by particular cytokines produced during
infection. However, such signaling pathways have not been
formally identified. We postulated that STAT3 may be a critical
factor in this process for a variety of reasons. STAT3-dependent
cytokines, such as IL-6, IL-10 and IL-21, have been implicated in
memory CD8+ T cell differentiation after vaccination and infec-
tion (Castellino and Germain, 2007; Foulds et al., 2006; Hinrichs
et al., 2008; Yi et al., 2010). STAT3 has an important role in the
differentiation other types of T cells including T helper 17
(Th17), Th2, and regulatory T (Treg) cells (Chaudhry et al.,
2009; Stritesky et al., 2011; Yang et al., 2007). Lastly, low
STAT3 activity is critical for embryonic stem cells to remain
undifferentiated and self-renew (Matsuda et al., 1999), and it
would be interesting if STAT3 functioned similarly in memory
CD8+ T cells.
This study reveals that STAT3 was required for formation of
mature, self-renewing, and protective memory CD8+ T cells.
Two upstream cytokines of STAT3, IL-10, and IL-21, acted
together to promotememoryCD8+ T cell differentiation and func-
tional maturation during LCMV infection. In the absence of
STAT3, KLRG1loIL-7Rhi MPCs formed, but these cells did not
accumulate and populate the memory CD8+ T cell pool as nor-
mally observed. Rather, thememoryCD8+ T cell pool that formed
was comprised mainly of TE-like cells that failed to undergo
homeostatic proliferation or protect against secondary infection.
During the effector-to-memory transition, the IL-10-IL-21-STAT3
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factors BCL-6, Eomes, and Blimp-1. In addition, expression of
the cytokine signaling inhibitor SOCS3 was also reduced and,
consequently, STAT3-deficient CD8+ T cells were hypersensitive
to IL-12 signaling. Thus, we propose that STAT3 promotes and
preserves memory cell potential in virus-specific CD8+ T cells
by sustaining the expression of ‘‘pro-memory’’ transcription
factors as well as proteins that shield T cells from responding to
effector-inducing inflammatory cytokines in the environment.
RESULTS
STAT3 Is Intrinsically Required for Memory CD8+ T Cell
Differentiation and Maturation
To examine the role of STAT3 in effector andmemory CD8+ T cell
development during viral infection, we generated mice in which
the activated CD8+ T cells would be STAT3 deficient by crossing
mice containing loxP-flanked Stat3 alleles (Stat3flox/flox) (Welte
et al., 2003) to mice expressing the Cre recombinase under the
control of the human Granzyme B promoter (GzB-cre) (Jacob
and Baltimore, 1999). For simplicity, the GzB-cre+; Stat3flox/flox
animals will be referred to as ‘‘Stat3/’’ and their littermate
controls (GzB-cre+; Stat3+/+ or GzB-cre; Stat3flox/flox) as
‘‘Stat3+/+’’ throughout the manuscript. Stat3/ and Stat3+/+
mice were infected acutely with lymphocytic choriomeningitis
virus (LCMV), and effector andmemory CD8+ T cell development
was analyzed. Proliferation of LCMV-specific effector CD8+
T cells (DbGP33-41 andD
bNP396-404) inStat3
/micewas compa-
rable to littermate control mice at day 8 postinfection (p.i.) (Fig-
ure 1A and Figure S1A available online). Additionally, clearance
of LCMV at day 8 p.i. and the formation of CD44hi KLRG1hi
CD27hi IL-7Rlo CD62Llo effector CD8+ T cells that produced
IFN-g, TNF-a, and Granzyme B were also similar between the
two groups of mice (Figures 1B, 1C, S1B, and S1C). There was
a slight reduction in the percentage of KLRG1lo IL-7Rhi effector
CD8+ T cells that contain MPCs (Figure 1C), but overall, effector
CD8+ T cell expansion, differentiation, and function at day 8 p.i
was not substantially altered in the absence of STAT3.
Next, we followed the development of Stat3+/+ and Stat3/
memory CD8+ T cells in the spleen and other tissues after
LCMV infection, and although there was no significant alter-
ations in the numbers or tissue distribution of GP33-41 and
NP396-404-specific memory CD8
+ T cells that formed up to
80 days p.i. (Figures 1A, S1A, and S1D), substantial differences
in the types of memory CD8+ T cells that formed in the spleen
were apparent. Whereas the Stat3+/+ memory cell pool con-
tained mostly KLRG1lo IL-7Rhi CD27hi cells and had accumu-
lated some CD62Lhi central memory T (Tcm) cells, the STAT3-
deficient memory CD8+ T cells resembled TE cells and were
predominantly KLRG1hiIL-7RloCD27loCD62Llo (Figures 1C–1E,
S1A, and S1B). BCL-2 expression was not affected by STAT3-
deficiency and increased in Stat3/ memory CD8 T cells as
typically observed after viral clearance (compare Figure S1C
and Figures 1E and 2C; Kaech et al., 2003). IL-15Rb (CD122)
expression was also unaffected (Figure 1E).
STAT3-deficient memory CD8+ T cells were functional and
produced IFN-g and TNF-a when restimulated (Figure 1F), but
they were less ‘‘polyfunctional’’ than Stat3+/+ cells because
very few made IL-2 (Figure 1E). Splenic Stat3/ memory CD8+IT cells also aberrantly sustained expression of GzmB after viral
clearance (Figure 1E). Moreover, the homing of STAT3-deficient
P14memory CD8+ T cells to all tissues was normal, except to the
lymph nodes and this was probably due to the Tcm cell deficit
(Figure S1E). Altogether, these results reveal that the formation
of phenotypically and functionally mature memory CD8+
T cells, including Tcm cells, is considerably impaired in the
absence of STAT3. Rather, the Stat3/ virus-specific CD8+
T cells persist long-term in more of an effector-like state.
Because GzB-cre mediated Stat3 deletion is not restricted
solely to CD8+ T cells, we verified that the above Stat3/ pheno-
types were CD8+ T cell autonomous by transferring small
number of LCMV-specific P14 Stat3/ CD8+ T cells (from P14
TCR-tg; GzB-cre+; Stat3flox/flox mice) into naive P14neg litter-
mates and examining their responses to LCMV infection. Indeed,
the phenotypes of P14 Stat3/ cells recapitulated all those
observed in polyclonal Stat3/memory CD8+ T cells described
above (Figure 2), with one notable exception. That is, compared
to the WT P14 CD8+ T cells, the STAT3-deficient P14 CD8+
T cells did not persist well over time despite normal BCL-2
expression (Figures 2A and 2C). Thus, STAT3 acts in a CD8+
T cell-autonomous manner to control memory CD8+ T cell differ-
entiation, and in a competitive setting, Stat3/ memory P14
CD8+ T cells are less fit and have a shortened life span compared
to WT memory T cells.
STAT3 Is Required forMemoryCD8+ TCell Self-Renewal
and Protective Immunity
Next, we examined whether Stat3/ memory CD8+ T cells
possess other cardinal memory properties such as the ability
to self-renew (i.e., homeostatically proliferate) and protect
against secondary infection. First, we infected Stat3+/+ and
Stat3/ mice with LCMV and fed them 5-bromodeoxyuridine
(BrdU) in their drinking water from days 30 to 40 p.i. The Stat3/
memory CD8+ T cells hadmarkedly reduced rates of BrdU incor-
poration, despite their normal expression of IL-15Rb and respon-
siveness to IL-15 (Figure 3A and data not shown). Second, we
adoptively transferred equal numbers of LCMV-specific memory
CD8+ T cells from Stat3+/+ and Stat3/ mice into naive recipi-
ents that were then infected with the more virulent LCMV Clone
13 strain. This showed that the secondary expansion of Stat3/
memory CD8+ T cells was reduced 90% relative to WT controls
and this correlated with poor viral control (Figure 3B,C). Similar, if
not more profound, defects in memory CD8+ T cell-mediated
protection were also observed in the P14 Stat3/ CD8+
T cells when rechallenged with either LCMV Clone 13 or re-
combinant Listeria monocytogenes that express LCMV GP-33
epitope (LM-33) (Figure S2 and data not shown). Thus, in the
absence of STAT3, the virus-specific CD8+ T cells retain a
TE-like phenotype and fail to form memory T cells that persist
well (in a competitive setting), self-renew, and provide protective
immunity to a secondary infection.
IL-10 and IL-21 Cooperatively Promote Memory CD8+ T
Cell Differentiation
To determine which extracellular signals might govern memory
CD8+ T cell development in a STAT3-dependent manner, we
examined the ability of LCMV-specific CD8+ T cells to respond
to several STAT3-dependent cytokines directly ex vivo bymmunity 35, 792–805, November 23, 2011 ª2011 Elsevier Inc. 793
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Figure 1. STAT3-Deficient Memory CD8+ T Cells Sustain a Terminally Differentiated Effector Phenotype
(A) Stat3+/+ (filled square) and Stat3/ (open circle) mice were infected with LCMV, and DbGP33-41-specific CD8
+ T cells in spleen were enumerated at days 8, 40,
and 80 p.i.
(B) Bar graphs show viral titers in the serum at day 8 p.i.; LOD denotes the level of detection. Serum from naive mice infected with CL13 served as a positive
control.
(C) Dot plots show expression of KLRG1 and IL-7R in DbGP33-41 tetramer
+ CD8+ T cells at day 8 and 80 p.i.
(D) Numbers of KLRG1lo IL-7Rhi and KLRG1hi IL-7Rlo subsets from (A and B) were plotted in line graphs.
(E) Histograms show the expression level of CD27, CD122, Granzyme B, and BCL-2 and the percentage of CD62L+ and IL-2+ in DbGP33-41 tetramer
+ Stat3+/+
(shaded histogram) and Stat3/ (dashed line histogram) CD8+ T cells at day 80 p.i.
(F) Dot plots show the IFN-g and TNF-a expression in GP33-41 peptide stimulated Stat3
+/+ and Stat3/ splenocytes at day 80 p.i. Data shown are representative
of at least three independent experiments per time point. MFI or percentage of ‘‘positive’’ cells (mean ± SEM) are shown in the upper-left or -right corner
throughout the whole manuscript.
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STAT3 Promotes Memory CD8+ T Cell Developmentmeasuring STAT3727 and STAT3705 phosphorylation via flow cy-
tometry. This analysis identified IL-10 and IL-21 as candidate
cytokines because both LCMV-specific effector and memory
CD8+ T cells responded to these cytokines (Figure S3A and
data not shown). To examine the roles of IL-10 and IL-21 on
effector and memory CD8+ T cell differentiation during LCMV
infection, we deprived cells of these cytokines using a combina-
tion of genetic and mAb blockade approaches. WT or Il21/
mice were infected with LCMV and either left alone or treated
with IL-10 mAb from days 1–25 p.i. The virus-specific CD8+
T cell responses were analyzed at days 8 and 25 p.i., and consis-
tent with previous reports in acute LCMV infection (Brooks et al.,
2010; Yi et al., 2010; Maris et al., 2007), mice lacking either IL-10
or IL-21 alone showed modest effects of these cytokines on
effector andmemoryCD8 T cell differentiation, function, and viral
clearance. Likewise, when both IL-10 and IL-21 were blocked
simultaneously, the ability to clear LCMV and produce IFN-g
and the numbers of virus-specific CD8 T cells recovered from
at day 25 p.i. were unaffected (Figures 4 and S3B–S3D).
However, in this latter group we observed that the formation
and persistence of KLRG1lo IL-7Rhi MPCs was significantly
impaired (Figure 4).This result suggests that IL-10 and IL-21
cooperate to promote memory CD8+ T cell maturation, and
deprivation of both cytokines recapitulates the phenotype found
in Stat3/ CD8+ T cells.
STAT3-Deficient CD8+ T Cells Have Reduced Eomes,
BCL-6, and Blimp-1 Expression
Being a transcription factor, STAT3 is likely to have multiple
downstream gene targets involved in memory CD8+ T cell devel-
opment. We first examined how STAT3 deficiency affects the
expression of other genes associated with effector and memory
CD8+ T cell fate decisions. Transcription factors such as BCL-6,
Eomes, and TCF-1 are involved in Tcm cell differentiation and
longevity, and others such as T-bet (Tbx21) and Blimp-1
(Prdm1) promote TEcell differentiation (Banerjee et al., 2010; Ichii
et al., 2007; Ichii et al., 2004; Intlekofer et al., 2005; Joshi et al.,
2007; Kallies et al., 2009; Rutishauser et al., 2009; Zhou et al.,
2010). Correlating with these roles, KLRG1hi IL-7Rlo TE cells
express greater amounts of Tbx21 and Prdm1, and conversely,
KLRG1lo IL-7Rhi MPCs express greater amounts ofBcl6, Eomes,
andTcf1 and these are important for Tcmcell formation (Banerjee
et al., 2010; Ichii et al., 2004; Ichii et al., 2007; Intlekofer et al.,
2007; Joshi et al., 2007; Rutishauser et al., 2009; Zhou et al.,
2010).We examined the expression of these transcription factors
and found that at day 8 p.i., the Stat3/ CD8+ T cells contained
comparable amounts of Eomes, T-bet, BCL-6, and Blimp-1
protein to the Stat3+/+ cells, indicating that STAT3 signaling
was not critical for normal expression of these proteins during
effector CD8+ T cell differentiation (Figures 5A and 5C). However,
the memory CD8+ T cells that formed in the absence of STAT3
had normal amounts of T-bet, but reduced amounts of Eomes,
BCL-6, and Blimp-1 compared to the Stat3+/+ cells (Figures 5B
and 5C). In agreement with prior studies in B cells (Ozaki et al.,
2004; Spolski and Leonard, 2008b), STAT3 may act directly on
BCL-6 in CD8+ T cells because this protein was elevated in
effector CD8+ T cells after treatment with IL-10 + IL-21, but the
same was not true for Eomes and T-bet (Figure S4; note,
Blimp-1 was not examined in these experiments). Together,Ithese data show that IL-10-IL-21-STAT3 signaling is necessary
for sustaining expression of particular transcription factors in
virus-specific CD8+ T cells during the effector to memory
transition.
BCL-6 Promotes Development of KLRG1lo IL-7Rhi
Memory CD8+ T Cells
Prior work has shown that Bcl6 mRNA expression is elevated in
IL-7Rhi effector cells relative to IL-7Rlo effector cells (Rutishauser
et al., 2009) and that Bcl6 is involved in the generation of CD8+
Tcm cells (Ichii et al., 2007; Ichii et al., 2004), but it has not been
examined whether Bcl6 is required intrinsically in CD8+ cells or
whether it is involved in the formation and persistence of KLRG1lo
IL-7Rhi MPCs. Because of the reduced BCL-6 expression in
Stat3/memoryCD8+T cells shownabove,wewanted to inves-
tigate these questions in greater detail. First, we measured the
amount of BCL-6 protein by using flow cytometry and found
that, indeed, the IL-7Rhi effector and memory CD8+ T cells
express greater amounts of BCL-6 relative to their IL-7Rlo coun-
terparts. Interestingly, BCL-6 expression progressively in-
creased within the IL-7Rhi cells during the effector-to-memory
transition, whereas the expression in the IL-7Rlo cells remained
stable (Figure 6A). To examine the intrinsic role ofBcl6 inmemory
CD8+ T cells, we made mixed bone marrow chimeras (BMCs) by
combining either Bcl6/ or Bcl6+/+ bone marrow with Cd8a/
bone marrow to generate mice containing Bcl6-deficient or
Bcl6-sufficient CD8+ T cells. After reconstitution, the two groups
of mice were infected with LCMV and effector andmemory CD8+
Tcell developmentwasmonitored at days 8and60p.i. At day 8,
the Bcl6/ effector CD8+ T cell population contained fewer
KLRG1lo IL-7Rhi MPCs on average, but this was not statistically
significant (Figure 6B). However, during the effector-to-memory
transition, the phenotypic differences between the two groups
grew more apparent and the Bcl6/ memory CD8+ T cell
population contained significantly fewer KLRG1lo IL-7Rhi cells
and more KLRG1hi IL-7Rlo cells (Figure 6B, C). Thus, BCL-6
is also important for the persistence and accumulation of
KLRG1lo IL-7Rhi in the memory CD8+ T cell population and the
similarity in phenotypes between Bcl6/ and Stat3/ CD8+
T cells suggests that reduced BCL-6 expression in the Stat3/
CD8+ T cells contributes to their impaired memory CD8+ T cell
development.
SOCS3 Suppresses IL-12 Signaling in Virus-Specific
CD8+ T Cells
In addition to the reduced expression of ‘‘pro-memory’’
genes Eomes and Bcl6, it is also possible that the Stat3/
virus-specific CD8+ T cells persist in TE or effector memory T
(Tem) cell states becauseStat3/CD8+ T cells aremore respon-
sive to proinflammatory cytokine signals, such as IL-12, that
drive effector cell differentiation. This idea stemmed from the
observation that suppressor of cytokine signaling 3 (SOCS3),
another well-characterized STAT3 target gene that degrades
Jak2, IL-6Ra, and other proteins to inhibit cytokine signaling
(Egwuagu et al., 2002; Yoshimura et al., 2007), was expressed
to a higher degree in IL-7Rhi MPCs compared to IL-7Rlo TE cells
after LCMV infection (Figure 7A). Additionally, Stat3/ effector
and memory CD8+ T cells expressed considerably less SOCS3
than their WT counterparts direct ex vivo (Figures 7B and S5A),mmunity 35, 792–805, November 23, 2011 ª2011 Elsevier Inc. 795
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Figure 2. STAT3 Acts in a CD8+ T Cell-Autonomous Manner to Generate a Long-Lived Pool of Mature Memory CD8+ T Cells
(A) Mice that received a small number (53 105) of P14 TCR-tg Stat3+/+ (filled square) and Stat3/ (open circle) cells were infected with LCMV. P14 CD8+ T cells in
spleen were enumerated at days 8, 40, and 80 p.i. Numbers of total P14, KLRG1lo IL-7Rhi, and KLRG1hi IL-7Rlo subsets were plotted in line graphs.
(B) Dot plots show the expression of KLRG1 and IL-7R in P14 CD8+ T cells at day 8 and 80 p.i.
(C) Histograms show the expression of CD27, CD122, Granzyme B, and BCL-2, and the percentage of CD62L+ and IL-2+ in P14 Stat3+/+ (shaded histogram) and
Stat3/ (dashed line histogram) CD8+ T cells at day 80 p.i. MFI or the percentage of ‘‘positive’’ cells are shown in the upper -left corner.
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Figure 3. STAT3 Is Required for Memory CD8+ T Cell
Self-Renewal and Protective Immunity
(A) LCMV-infected mice were given BrdU in drinking water
from days 30 to 40 p.i., and BrdU incorporation (±SEM) in
Stat3+/+ (solid line) and Stat3/ (dashed line) memory CD8+
T cell and isotype control (shaded) is shown in histograms.
(B and C) Equal numbers of Stat3+/+ and Stat3/ LCMV-
specific memory CD8+ T cells were adoptively transferred into
naive hosts that were subsequently infected with LCMV Cl13.
A control group of ‘‘Naive’’ mice that did not receive donor
memory CD8+ T cells are also shown. Bar graphs show the
numbers of secondary effector CD8+ T cells (B) and serum
viral titers (C) in the recipient mice at day 6 p.i. Data shown are
representative of three independent experiments (**p < 0.01).
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STAT3 Promotes Memory CD8+ T Cell Developmentand SOCS3 could be induced or maintained in LCMV-specific
CD8+ T cells in a STAT3-dependent manner when cultured with
IL-10 and IL-21 in vitro (Figure 7C). We tested whether elevated
SOCS3 could dampen IL-12-dependent phosphorylation of
STAT4693 signaling by retroviral (RV) overexpression of SOCS3
in activated CD8+ T cells and found that this was sufficient to
suppress IL-12-induced STAT4693 phosphorylation (Figure 7D).Immunity 35, 79Furthermore, activated CD8+ T cells pretreated
with IL-10 and IL-21 in vitro for 48 hr prior to IL-12
stimulation contained lower amounts of phosphor-
ylated STAT4 than control cells that were not
exposed to IL-10 and IL-21 (Figure S5B). More
importantly, we observed that compared to
Stat3+/+ effector and memory CD8+ T cells,
Stat3/ cells were hyperresponsive to IL-12
signaling and STAT4693 phosphorylation in vitro
(Figure 7E) or directly ex vivo 1 day after Listeria
monocytogenes infection, which potently induces
IL-12 production (Figure 7F). Type I IFNs also acti-
vate STAT4 in effector CD8+ T cells (Nguyen et al.,
2002). Therefore, we examined STAT4 phosphory-
lation in Stat3/ effector CD8+ T cells after in vitro
IFN-b stimulation and found comparable amounts
of pSTAT4693 between Stat3
+/+ and Stat3/
effector CD8+ T cells (data not shown). These
results show that STAT3-deficient cells are particu-
larly more responsive to IL-12 signaling and
suggest that increased basal STAT4 activity by
bystander inflammatory cytokines sustains effector
states in the Stat3/ CD8+ T cells.
To further evaluate the effects of SOCS3 in
preserving memory CD8+ T cell fates, we knocked
down (KD) SOCS3 in LCMV-specific CD8+ T cells
by using shRNAi RV transduction of P14 CD8+
T cells (Figure S5C). Although SOCS3 KD had little
impact on effector CD8+ T cell differentiation and
function (Figures S5D–S5F), it impaired themainte-
nance of KLRG1lo IL-7Rhi memory CD8+ T cells
(Figure 7G). However, the SOCS3 KD effect was
not as robust as STAT3 deficiency, suggesting
that other genes downstream of STAT3 are
involved in this process. Taken together, these
data support a model that STAT3 serves two majorroles in virus-specific CD8+ T cells. One is to sustain expression
of transcription factors that enhance formation of long-lived,
self-renewing memory CD8+ T cells (such as BCL-6 and Eomes)
and the other is to ‘‘insulate’’ virus-specific CD8+ T cells, via
SOCS3, from inflammatory signals (e.g., IL-12) that drive TE
differentiation, thereby preserving memory cell potential in
a proportion of the surviving cells.2–805, November 23, 2011 ª2011 Elsevier Inc. 797
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(A) WT and Il21/ mice were infected with LCMV and either treated with aIL-10 mAb or mock injected with PBS for 25 days. KLRG1 and IL-7R expression on
DbGP33-41 tetramer
+ CD8+ T cells was examined at days 25 p.i.
(B) The numbers of total DbGP33-41 tetramer
+ (open bars) and KLRG1lo IL-7Rhi (black bars) CD8+ T cells at day 25 p.i. are shown in the stacked bar graphs.
Data shown are representative of two independent experiments (statistical analyses show the comparison between KLRG1lo IL-7Rhi groups; *p < 0.05 and n.s.,
not significant).
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After acute viral or bacterial infection, a subset of memory
precursor cells arise from a heterogeneous effector cell pool,
and these cells progressively differentiate into functionally
mature memory T cells that are long-lived and possess
increased capacity to proliferate to antigen and homeostatic
cytokines (e.g., IL-15) (Cui and Kaech, 2010; Kaech et al.,
2002; Kaech and Wherry, 2007). Heightened or prolonged anti-
genic stimulation, inflammation, IL-2 signaling, and mTOR
activity promote terminal differentiation of effector CD8+ T cells
(Agarwal et al., 2009; Araki et al., 2009; Badovinac et al., 2005;
Badovinac et al., 2004; Cui and Kaech, 2010; Joshi et al.,
2007; Kalia et al., 2010; Kolumam et al., 2005; Nguyen et al.,
2002; Pearce et al., 2009; Sarkar et al., 2008), whereas truncation
of these signals at priming and effector phase of the immune
response accelerates memory development (Badovinac et al.,798 Immunity 35, 792–805, November 23, 2011 ª2011 Elsevier Inc.2005; Badovinac et al., 2004; Cui et al., 2009; Kalia et al.,
2010; Sarkar et al., 2008). Recently, increasing evidence also
suggests that further signals are required during the effector-
to-memory transition stage for memory cells to gradually mature
(Kaech et al., 2002; Sun et al., 2004). In this study, we demon-
strated that, together, IL-10 and IL-21 are critical cytokines for
promoting and maintaining memory cell formation and matura-
tion and that STAT3 is an integral mediator of those cytokines.
In the absence of STAT3, KLRG1lo IL-7Rhi MPCs formed (albeit
at a slightly reduced frequency), but this population did not pref-
erentially populate the memory pool as normally observed.
STAT3 enhanced survival of memory CD8+ T cells in a competi-
tive setting and was necessary for sustaining expression of
transcriptional regulators, such as BCL-6 and Eomes, which
helped MPCs persist and mature into self-renewing Tcm cells.
We propose that the STAT3-dependent expression of SOCS3
acts as an ‘‘insulator’’ of memory cell potential to prevent
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Figure 5. Stat3–/– CD8+ T Cells Have Reduced Expression of Eomes and BCL-6
(A and B) Histogram plots showing the expression of Eomes, T-bet, and BCL-6 in DbGP33-41 tetramer
+Stat3+/+ (shaded) andStat3/ (dashed line) CD8+ T cells at
days 8 (A) and 40 (B) p.i.
(C) Immunoblot shows the amount of Blimp-1 and Actin (loading control) in P14 CD8+ T cells isolated at days 8 and 40 p.i. by FACS. Numbers below the graph
indicate the normalized abundance of Blimp-1 measured by densitometry.
Immunity
STAT3 Promotes Memory CD8+ T Cell Developmentvirus-specific CD8+ T cells from responding to inflammatory
cytokines (such as IL-12) present during infection or basally
that induce TE differentiation. Together, these data create a
model wherein the induction and maintenance of memory
CD8+ T cell fates is an active, rather than default, process that
is dependent on cytokines that sustain expression of ‘‘pro-
memory’’ transcription factors as well as proteins that shield
T cells from responding to effector-inducing inflammatory cyto-
kines in the environment.
Consistent with our data, human studies have found that
memory T cells from patients with autosomal-dominant hyper
IgE syndrome (AD-HIES), whom carry dominant-negative STAT3
alleles, share several of the phenotypic abnormalities described
here in murine memory CD8+ T cells. AD-HIES patients have
reduced numbers of memory T cells, especially Tcm cells, and
T cells from AD-HIES patients are impaired from adopting Tcm
cell traits when stimulated in vitro. The AD-HIES memory
CD8+ T cells also show reduced BCL6, and SOCS3 expres-
sion. Most importantly, many AD-HIES patients are unable toIcontrol latent Epstein-Barr Virus (EBV) and Varicella Zoster
Virus (VZV) infection and have considerably elevated EBV viral
titers compared to healthy subjects (Siegel et al., 2011). Thus,
STAT3 is an important regulator of memory T cells in both mouse
and man.
Interestingly, although STAT3-deficient virus-specific CD8+
T cells fail to form functional memory cells, these KLRG1hi IL-7Rlo
TE-like cells could persist for several months. This was unex-
pected given that cells with this phenotype tend to be shorter-
lived (Joshi et al., 2007). However, our data show that one feature
of Stat3/ memory cells that differs from early effector TE cells
is BCL-2 expression; BCL-2 accumulated in Stat3/ memory
cells normally after viral clearance (Kaech et al., 2003; Tripathi
et al., 2010). KLRG1hi IL-7Rlo TE cells depend on IL-15 and there
was also no defect in IL-2 and IL-15 receptor b chain (CD122)
expression in Stat3/ memory cells. Lastly, gene expression
profiling revealed that Stat3/ CD8+ T cells expressed greater
than normal amounts of Spi2A, another prosurvival factor for
memory CD8+ T cells (Liu et al., 2004). Thus, it is possible thatmmunity 35, 792–805, November 23, 2011 ª2011 Elsevier Inc. 799
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Figure 6. BCL-6 Is Important for Maintaining KLRG1lo IL-7Rhi Memory CD8+ T Cells after Infection
(A) Histograms show the expression of BCL-6 in LCMV-specific IL-7Rhi (black line) and IL-7Rlo (shaded) subsets at day 8 and 40 p.i. based on intracellular staining
and flow cytometry.
(B) Cd8a/ bone marrow was mixed with either Bcl6/ or Bcl6+/+ bone marrow (at a 90:10 ratio) and used for reconstituting irradiated Cd8a/mice that were
then infected with LCMV 2 months later. DbNP396-404 tetramer
+ CD8+ T cells were examined for expression of KLRG1 and IL-7R at days 8 and 60 p.i.
(C) Numbers of total (open) or KLRG1lo IL-7Rhi (solid) DbNP396-404
+ memory CD8+ in spleen at day 60 were plotted in the bar graphs. Data shown are repre-
sentative of two independent experiments (**p < 0.01).
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STAT3 Promotes Memory CD8+ T Cell Developmentthese factors combined account for the persistence of Stat3/
memory CD8+ T cells.
An important finding in this study is that IL-10 and IL-21 coop-
erate to induce memory CD8+ T cell fates and promote their
maturation during LCMV infection. Prior work has implicated
IL-10 and IL-21 in memory CD8+ T cell differentiation and in
agreementwith recent reports, we found Il21/mice had slightly
reducedpolyfunctional Tcmcell formation during LCMV infection
(Yi et al., 2010). However, IL-21 may have more profound roles in
the expansion and survival of effector CD8+ T cells and persis-
tenceofmemorycells in other typesof infectionssuchasvaccinia
virus and adenovirus (Barker et al., 2010; Novy et al., 2011).
Although it remains to be investigated more rigorously, CD4+
T cells are likely the physiological cell source for IL-21 (Spolski
and Leonard, 2008a); thus, IL-21 production represents a key
aspect of CD4+ T cell help provided to memory CD8+ T cells
during infection. However, it will be important to determine
whether CD4+ T cells secrete IL-21 in a trophic manner to
‘‘help’’ CD8+T cells or if it is delivered toCD8+ T cells by particular
types of CD4+ T cells during immune responses.
IL-10 is traditionally thought of as an ‘‘anti-inflammatory’’ cyto-
kine, and therefore its role in promoting memory CD8+ T cell
development may seem counterintuitive. Although IL-10-defi-
ciency alone does not strongly perturb LCMV-specific CD8
T cell responses during acute infection (Brooks et al., 2010;Maris
et al., 2007), IL-10 does support memory CD8+ T cell develop-
ment during Listeria infection because fewer antigen-specific
memory CD8+ T cells formed in Il10/ mice compared to wild-
type controls (Foulds et al., 2006). However, another study
analyzed the responses of Il10rb/ CD8+ T cells during Listeria
infection and their results suggested that IL-10 acts directly to
suppress antigen-specific CD8+ T cell clonal expansion (Biswas
et al., 2007). In the absence of IL-10R signaling, greater numbers
of memory CD8+ T cells formed as a result of the increased
expansion (Biswas et al., 2007). Synthesizing all the data, we
postulate that IL-10 simultaneously acts in both a direct and indi-
rect manner to promote memory CD8+ T cell development. On
the one hand, IL-10 may act directly on CD8+ T cells to repress
proliferation and induce SOCS3 and other STAT3-dependent
genes that ‘‘insulate’’ and promote development of memory
CD8+ T cells and their precursors. On the other hand, IL-10
may also act indirectly as an anti-inflammatory cytokine to
antagonize production of IL-12, type I IFNs, and other inflamma-
tory cytokines that drive TE differentiation during infection. Thus,
IL-10 probably serves a compound role to promote and preserve
MPC fates, and an IL-10 deficiency may have a larger effect on
memory CD8+ T cell development than specific deletion of
IL-10R signaling in CD8+ T cells. Given that many cells can
produce IL-10, it will be interesting to determine the pertinent
cell types involved in this process. In addition, although it
remains to be determined more precisely how the STAT3 tran-
scriptional activity is differentially regulated in MPC versus TE
or Tcm versus Tem cells, it does not probably stem from asym-
metric expression of STAT3 or IL-10 and IL-21 receptors
because all the subsets phosphorylated STAT3 fairly equiva-
lently after stimulation with these two cytokines (data not shown).
Lastly, it remains unclear whether IL-10 and IL-21 function indi-
vidually at different phases of the immune response or in an over-
lapping fashion to preserve memory potential and promoteImemory maturation. It will be important to further dissect
whether a IL-10-IL-21-STAT3 signaling cascade is required to
induce or maintain MPC fates, or both.
Our data show that STAT3 is a key integrator of multiple signal
inputs and outputs to coordinate effector and memory differen-
tiation. Two important signal outputs of STAT3 in CD8+ T cells
are Eomes and BCL-6 that, interestingly, both function to
enhance survival of IL-7Rhi cells and development of Tcm cells
(Banerjee et al., 2010; Ichii et al., 2007; Ichii et al., 2004). Recent
data showed that Eomes could be regulated by TCF-1 and Wnt
signals (Zhou et al., 2010), and it remains to be determined
whether the reduction of Eomes expression observed inStat3/
CD8+ T cells similarly stems from decreased Tcf1 expression or
whether the Wnt-TCF-1 and IL-21-IL-10-STAT3 function as
parallel pathways for regulating Eomes expression. Although
the T-box factors Eomes and T-bet coordinate to regulate CTL
differentiation (Intlekofer et al., 2008; Pipkin et al., 2010), they
are also expressed in a reciprocal manner to a certain degree
with KLRG1lo IL-7Rhi effector cells and Tcm cells expressing
more Eomes than KLRG1hi IL-7Rlo and Tem cells (Banerjee
et al., 2010; Intlekofer et al., 2007). Thus, the ratio of these tran-
scription factors in CD8+ T cells appears to be critical determi-
nants of their long-term fates. Similarly, in extension to our prior
study (Rutishauser et al., 2009), this report shows that BCL-6 and
Blimp-1, two additional STAT3 target genes (Calame, 2008;
Diehl et al., 2008; Ozaki et al., 2004; Spolski and Leonard,
2008b), function in a reciprocal manner in CD8+ T cells; Blimp-
1 promotes TE differentiation and BCL-6 promotes MPC and
Tcm cell formation. We also show that BCL-6 expression
increases overtime as memory CD8+ T cells mature and Tcm
cells accumulate, and we postulate that this relies on sustained
IL-21-STAT3 signaling after viral infection. Sustained Blimp-1
expression in memory CD8+ T cells was also dependent on
Stat3 and this was somewhat surprising given that Stat3/
CD8+ T cells maintained several TE-like attributes. Several
possible explanations may account for this result; for instance,
it is possible that Blimp-1 predominantly acts during effector
CD8+ T cell differentiation to induce TE-fates, but is dispensable
at later times. Alternatively, despite the reduced expression of
Blimp-1 and BCL-6 in Stat3/ cells, it is possible that the overall
ratio of the two factors remains unaffected such that TE fates
dominate over time. It will be interesting to determine whether
the STAT3-dependent cytokines that function during the
effector-to-memory transition to sustain Blimp-1 and BCL-6
expression in virus-specific CD8+ T cells are one and the same
or different. IL-21 is a likely candidate given that it induces the
expression of both transcription factors in B cells (Calame,
2008; Diehl et al., 2008; Ozaki et al., 2004; Spolski and Leonard,
2008b), and if true, this would suggest that the same cytokine
could simultaneously promote divergent cell fates in a ‘‘con-
text-dependent manner’’ that would be determined by additional
STAT3 cofactors in the MPC and TE subsets.
SOCS3 is an important target of STAT3 in CD8+ T cells and we
propose that SOCS3 acts as an insulator to shield MPCs from
cytokine signals that drive TE fates. Interestingly, like SOCS3,
expression of SOCS1 is also increased in MPCs relative to TE
cells (data not shown). Possibly, additional suppressors of cyto-
kine signaling are involved in memory cell fate specification and
maintenance. IL-21-STAT3 signaling pathway can also inducemmunity 35, 792–805, November 23, 2011 ª2011 Elsevier Inc. 801
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(A) Immunoblot shows the amount of SOCS3 and GRP94 (loading control) in KLRG1hi IL-7Rlo (TE) or KLRG1lo IL-7Rhi (MPC) P14 CD8+ T cells isolated by FACS
8 days p.i. Numbers below the graph indicate the normalized amount of SOCS3 measured by densitometry.
(B) Histogram plots showing the expression of SOCS3 in DbGP33-41 tetramer
+ Stat3+/+ (shaded) and Stat3/ (dashed line) CD8+ T cells at days 8 and 40 p.i.
(C) SOCS3 expression in P14 Stat3+/+ or Stat3/ LCMV-specific day 6 effector CD8+ T cells treated in vitro with IL-10 and IL-21 for 8 hr (black line) or left
untreated (shaded).
(D) Activated P14 CD8+ T cells were transduced with retroviruses (RV) containing MigR1 empty vector or MigR1-SOCS3, stimulated with IL-12 (black line) or left
untreated (dashed line), and then the amount of pSTAT4693 was measured by flow cytometry.
(E) Histogram plot (left) shows the levels of pSTAT4693 in day 7 P14 Stat3
+/+ (shaded) and Stat3/ (dashed line) effector CD8+ T cells after IL-12 (10 ng ml1)
stimulation. The gray line shows untreated control cells. The line graph (right) showsMFI of pSTAT4693 (normalized to unstimulated controls) in day 7 P14 Stat3
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(F) Plots show the amount of pSTAT4693 directly ex vivo in P14 Stat3
+/+ (shaded) and Stat3/ (dashed line) LCMV-specific memory CD8+ T cells 1 day after
infection with Listeria monocytogenes.
(G) Activated P14 CD8+ T cells were transduced with control RV (MigR1) or a SOCS3 shRNAi RV and adoptively transferred into C57BL/6 mice that were
subsequently infected with LCMV. Contour plots show expression of KLRG1 and IL-7R in the RV transduced cells at day 30 p.i. Data shown are representative of
at least three independent experiments.
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STAT3 Promotes Memory CD8+ T Cell DevelopmentSOCS1 expression in T cells (Palmer and Restifo, 2009), and this
may explain the partial effect of SOCS3 KD on KLRG1lo IL-7Rhi
Tcm cell differentiation. Altogether, the identification of the
IL-10-IL-21-STAT3 pathway as a pivotal regulator of memory
CD8+ T cell development provides important mechanistic insight
that could lead to novel immunotherapies and enhance vaccine
development.
EXPERIMENTAL PROCEDURES
Mice
Stat3flox/flox mice were originally generated by X.-Y. Fu (Welte et al., 2003)
(Indiana University School of Medicine, Indianapolis, IN) and obtained from
P. Lee (Yale University School of Medicine, New Haven, CT). Granzyme
B-Cre (Gzm-Cre+) mice were kindly provided by J. Jacobs (Emory University,
Atlanta, GA) via R. Flavell’s lab (Yale University School of Medicine, New
Haven, CT) and were crossed to Stat3flox/flox mice for generation of GzB-cre+;
Stat3flox/flox (Stat3/) mice and GzB-cre+; Stat3+/+ or GzB-cre; Stat3flox/flox
(Stat3+/+) mice. Stat3/ and Stat3+/+ mice were further crossed to P14 TCR
transgenic (tg) mice so that P14 Stat3/ and P14 Stat3+/+ mice could be
created. Cd8a/ and Il21/ mice were purchased from Jackson Laborato-
ries (Bar Harbor, ME) and Taconic (Hudson, NY), respectively. Bcl6/ mice
were kindly provided by A. Dent (Indiana University School of Medicine,
Indianapolis, IN). All animal experiments were done with approved institutional
animal care and use committee protocols.
Infections and Treatments
For infections of mice, 23 105 PFU of the LCMV Armstrong strain were admin-
istered intraperitoneally (i.p.). For recall experiments, mice were infected with
23 106 PFU of the LCMV clone 13 strain intravenously (i.v.). For BrdU labeling,
BrdU (1mg mL1) was administered in the drinking water daily for at least
10 days. For IL-10 blockade, aIL-10 mAb antibody (JES5-2A5 clone, kindly
provided by J.M.M. den Haan, UV University Medical Center, Amsterdam,
Netherland) was administered 0.5 mg ml1 i.p. every other day for indicated
period of time in accordance with the experiments.
Bcl6–/– Mixed Bone Marrow Chimeras
To generate mixed bone marrow chimeras, we mixed bone marrow from
Cd8+a/ animals in a 90:10 ratio with bone marrow from either Bcl6+/+ or
Bcl6/ and used it to reconstitute lethally irradiated C57/B6 recipient mice.
Two months later, these mice were infected with LCMV, and lymphocytes
were isolated from tissues as described previously (Rutishauser et al., 2009).
Retroviral Transduction
P14 Stat3/ mice were directly infected with 2 3 106 PFU LCMV-Armstrong
i.v. and 1 day later, P14 Stat3/ splenocytes were spin-transduced for 90 min
at 37C with fresh viral supernatants from 293T cells (transfected with Eco-
helper and either MigR1 control, MigR1-SOCS3 or MSCV-SOCS3-shRNAi
plasmids in the presence of 8 mg mL1 polybrene and 10 ng mL1 IL-2) and
then 0.5 3 106 splenocytes were transferred i.v. to recipient mice that were
subsequently infected with LCMV.
Surface and Intracellular Staining and Antibodies
All antibodies were purchased from eBiosciences (San Diego, CA) and BD
Biosciences (San Jose, CA), except anti-Granzyme B PE (Caltag, Burlingame,
CA), anti-BCL-6 PE (Santa Cruz Biotechnology, Santa Cruz, CA), and anti-
KLRG1 (2F1, was kindly provided by D. Raulet, University of California, Berke-
ley, CA). Class I MHC tetramers were generated as described previously
(Kaech et al., 2003). All flow cytometry was analyzed on a FACSCalibur or
LSRII (BD) with FlowJo software (Treestar, San Carlos, CA).
pSTAT4693 Staining
For in vitro assays, P14 effector CD8+ T cells were harvested and incubated
with IL-12 in vitro with culture media for 30 min. Cells were fixed with cytofix
and permeabilized with 90% methanol, then stained intracellularly with
pSTAT4693 antibody. For in vivo assays, we first infected mice containing
5 3 104 naive P14 Stat3+/+ and Stat3/ CD8+ T cells with LCMV and waitedI40 days until memory P14 cells were formed. We then infected these immune
mice with 23 104 CFU Listeria monocytogenes i.v. One day later, splenocytes
were harvested and a cell suspension wasmade directly in cytofix, and subse-
quently the suspension was stained with pSTAT4693 antibody as described
above.
Immunoblot Analysis
Protein lysates from 13 106 day 8 LCMV-specific total (CD8+CD44+ CD62L),
KLRG1hi IL-7Rlo or KLRG1lo IL-7Rhi sorted effector CD8+ T cells were lysed
and resolved by SDS-PAGE. Blimp-1 (Santa Cruz Biotechnology, Santa
Cruz, CA), SOCS3 (Cell Signaling Technology, Danvers, MA), Actin (Sigma-
Aldrich, St. Louis, MO), and GRP94 (Enzo Life Sciences, Plymouth Meeting,
PA) were detected by immunoblotting. The abundance of each protein expres-
sion was measured by densitometry with ImageJ 1.43u software (NIH).
Statistical Analyses
Where indicated, p values were determined by a two-tailed unpaired Student’s
t test. p values < 0.05 were considered significant. All graphs show averages of
the mean ± SEM.SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and can be found with this
article online at doi:10.1016/j.immuni.2011.09.017.
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